Case Study Primary Plasma Cell Leukaemia

Plasma cell leukemia (PCL) is a rare form of malignant plasma cell dyscrasia. It can occur as a primary form without prior evidence of multiple myeloma or as a secondary form which is a terminal event in multiple myeloma. It is characterised by a proliferation of plasma cells in blood and the bone marrow. The outcome of plasma cell leukemia is poor with conventional therapy. Here we illustrate a case of primary plasma cell leukemia complicated by paraplegia. The patient initially responded to combination chemotherapy but succumbed to the disease two months after presentation.

[1]  B. Seo,et al.  Combination chemotherapy with bortezomib, cyclophosphamide and dexamethasone may be effective for plasma cell leukemia. , 2007, Japanese journal of clinical oncology.

[2]  R. Andreesen,et al.  Complete remission and successful stem cell mobilization after treatment of refractory plasma cell leukemia with bortezomib , 2006, Annals of Hematology.

[3]  K. Pavithran,et al.  Primary plasma cell leukemia occuring in the young. , 2003, Indian journal of cancer.

[4]  R. Kordek,et al.  Aggressive Primary Plasma Cell Leukemia with Skin Manifestations, Trisomy 8 and Molecular Oligoclonal Features , 2002, Leukemia & lymphoma.

[5]  E. Hatzimichael,et al.  Treatment of plasma cell leukemia with vincristine, liposomal doxorubicin and dexamethasone , 2001, European journal of haematology.

[6]  R. Bouabdallah,et al.  Primary plasma cell leukaemia: a report of 18 cases. , 2001, Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis.

[7]  A. Órfão,et al.  Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics. , 1999, Blood.

[8]  P. Chiusolo,et al.  Long-lasting complete remission in plasma cell leukemia after aggressive chemotherapy and CD34-selected autologous peripheral blood progenitor cell transplant: molecular follow-up of minimal residual disease , 1998, Bone Marrow Transplantation.

[9]  E. Vellenga,et al.  Consolidation therapy with autologous stem cell transplantation in plasma cell leukemia after VAD, high-dose cyclophosphamide and EDAP courses: a report of three cases and a review of the literature , 1997, Bone Marrow Transplantation.

[10]  A. Palumbo,et al.  Primary plasma cell leukaemia , 1994, British journal of haematology.

[11]  R. Kyle,et al.  Plasma cell leukemia: an evaluation of response to therapy. , 1987, The American journal of medicine.